NCT05945095 is a NA clinical trial of Gum chewing group in Mothers, sponsored by Artvin Coruh University.

Who is sponsoring NCT05945095?

NCT05945095 is sponsored by Artvin Coruh University.

What drugs are being tested in NCT05945095?

Interventions in NCT05945095: Gum chewing group.

What condition does NCT05945095 study?

NCT05945095 studies Mothers, Cesarean Section Complications.

Is NCT05945095 still recruiting?

NCT05945095 is currently status unknown. Last updated 14 July 2023.

Last reviewed 2023-07-14 · How we verify

NCT05945095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Chewing Gum After Cesarean Section on Gastrointestinal System Functions, Pain and Sleep Quality

Status unknown NA Last updated 14 July 2023

What this trial tests

NA trial testing Gum chewing group in Mothers in 60 participants. Status unknown.

Timeline

27 March 2023

Primary endpoint
27 December 2023

20 May 2024

Quick facts

Lead sponsor	Artvin Coruh University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	27 March 2023
Primary completion	27 December 2023
Estimated completion	20 May 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Gum chewing group

Conditions studied

Mothers — all drugs for Mothers →
Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

Artvin Coruh University

Who can join

18 and older, female only, with Mothers or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be conducted on mothers who had planned cesarean section.After the birth, the information about the surgery in the personal information form will be completed. Then, mothers in the control group will be given standard postpartum care. The mothers in the experimental group, on the other hand, will chew sugar-free gum for at least 15 minutes, starting from the second hour after the surgery. The gum chewing process will be repeated every two hours. Mothers will be mobilized at the 8th sat after the birthday. Pain levels of mothers in both groups will be evaluated every two hours after delivery. In addition, the amount of analgesic use will be compared and comments will be made on the level of pain. The sleep quality of the postpartum women will be questioned the day after the cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mothers

Currently open trials in the same condition.

NCT06999928 — Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV · NA · recruiting
NCT06917417 — The Effect of Laughter Therapy on Marital Adjustment, Life Satisfaction and Maternal Attachment Level in Mothers · NA · recruiting
NCT06371469 — Program of Health Behaviour Against to Cancer (PHeBAC) · NA · recruiting

Other Artvin Coruh University trials

Trials by the same sponsor.

NCT07242898 — Clinically Important or Just Statistically Significant? MCID for DVISS and PIN-Q in Children With UI · NA · not yet recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07400874 — Use of Acupressure, Aromatherapy, and Virtual Reality for Children in During Blood Collection Procedures · NA · not yet recruiting
NCT07383935 — Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients · NA · recruiting
NCT07367269 — Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05945095 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Artvin Coruh University
Last refreshed: 14 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05945095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing